VIM and plasma cell leukemia: LncRNA LY86-AS1 and lncRNA VIM-AS1 were significantly upregulated in the MM patients in comparison to the PCL patients (p ≤ 0.05) The subsequent ROC revealed that it was possible to distinguish between the MM and PCL patients with a high sensitivity and specificity for both lncRNAs.